Neil W. Peterson - 03 Mar 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
03 Mar 2025
Net transactions value
-$253,000
Form type
4
Filing time
04 Mar 2025, 21:07:17 UTC
Previous filing
03 Mar 2025
Next filing
02 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $272,000 +5,000 +18% $54.40 33,369 03 Mar 2025 Direct F1
transaction MMSI Common Stock, No Par Value Sale $525,000 -5,000 -15% $105.00 28,369 03 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5,000 -33% $0.000000 10,000 03 Mar 2025 Common Stock 15,000 $54.40 Direct F1, F2
holding MMSI Non-qualified stock options (right to buy) 25,000 03 Mar 2025 Common Stock 25,000 $68.33 Direct F3
holding MMSI Non-qualified stock options (right to buy) 13,576 03 Mar 2025 Common Stock 13,576 $70.58 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.
F2 Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.
F3 Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
F4 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.